|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kandoth C, Schultz N, Cherniack AD, Akbani
R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, Benz CC, et al
Cancer Genome Atlas Research Network: Integrated genomic
characterization of endometrial carcinoma. Nature. 497:67–73. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Amant F, Mirza MR, Koskas M and Creutzberg
CL: Cancer of the corpus uteri. Int J Gynaecol Obstet. 131(Suppl
2): S96–S104. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Psaila B and Lyden D: The metastatic
niche: Adapting the foreign soil. Nat Rev Cancer. 9:285–293. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Valastyan S and Weinberg RA: Tumor
metastasis: Molecular insights and evolving paradigms. Cell.
147:275–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen H, Xu C, Jin Q and Liu Z: S100
protein family in human cancer. Am J Cancer Res. 4:89–115.
2014.PubMed/NCBI
|
|
7
|
Donato R, Cannon BR, Sorci G, Riuzzi F,
Hsu K, Weber DJ and Geczy CL: Functions of S100 proteins. Curr Mol
Med. 13:24–57. 2013. View Article : Google Scholar :
|
|
8
|
Lee SJ, Choi SY, Kim WJ, Ji M, Lee TG, Son
BR, Yoon SM, Sung R, Lee EJ, Youn SJ, et al: Combined aberrant
expression of E-cadherin and S100A4, but not β-catenin is
associated with disease-free survival and overall survival in
colorectal cancer patients. Diagn Pathol. 8:992013. View Article : Google Scholar
|
|
9
|
Dahlmann M, Okhrimenko A, Marcinkowski P,
Osterland M, Herrmann P, Smith J, Heizmann CW, Schlag PM and Stein
U: RAGE mediates S100A4-induced cell motility via MAPK/ERK and
hypoxia signaling and is a prognostic biomarker for human
colorectal cancer metastasis. Oncotarget. 5:3220–3233. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee SH, Kim H, Hwang JH, Shin E, Lee HS,
Hwang DW, Cho JY, Yoon YS, Han HS and Cha BH: CD24 and S100A4
expression in resectable pancreatic cancers with earlier disease
recurrence and poor survival. Pancreas. 43:380–388. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Burock S, Herrmann P, Wendler I,
Niederstrasser M, Wernecke KD and Stein U: Circulating metastasis
associated in colon cancer 1 transcripts in gastric cancer patient
plasma as diagnostic and prognostic biomarker. World J
Gastroenterol. 21:333–341. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hernández JL, Padilla L, Dakhel S, Coll T,
Hervas R, Adan J, Masa M, Mitjans F, Martinez JM, Coma S, et al:
Therapeutic targeting of tumor growth and angiogenesis with a novel
anti-S100A4 monoclonal antibody. PLoS One. 8:e724802013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chong HI, Lee JH, Yoon MS, Suh DS, Kim K,
Kim JY and Choi KU: Prognostic value of cytoplasmic expression of
S100A4 protein in endometrial carcinoma. Oncol Rep. 31:2701–2707.
2014.PubMed/NCBI
|
|
14
|
Xie R, Loose DS, Shipley GL, Xie S,
Bassett RL Jr and Broaddus RR: Hypomethylation-induced expression
of S100A4 in endometrial carcinoma. Mod Pathol. 20:1045–1054. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zheng H and Kang Y: Multilayer control of
the EMT master regulators. Oncogene. 33:1755–1763. 2014. View Article : Google Scholar
|
|
17
|
Kidd ME, Shumaker DK and Ridge KM: The
role of vimentin intermediate filaments in the progression of lung
cancer. Am J Respir Cell Mol Biol. 50:1–6. 2014.
|
|
18
|
Wang H, Shi J, Luo Y, Liao Q, Niu Y, Zhang
F, Shao Z, Ding Y and Zhao L: LIM and SH3 protein 1 induces
TGFβ-mediated epithelial-mesenchymal transition in human colorectal
cancer by regulating S100A4 expression. Clin Cancer Res.
20:5835–5847. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lo JF, Yu CC, Chiou SH, Huang CY, Jan CI,
Lin SC, Liu CJ, Hu WY and Yu YH: The epithelial-mesenchymal
transition mediator S100A4 maintains cancer-initiating cells in
head and neck cancers. Cancer Res. 71:1912–1923. 2011. View Article : Google Scholar
|
|
20
|
Nitta T, Mitsuhashi T, Hatanaka Y,
Miyamoto M, Oba K, Tsuchikawa T, Suzuki Y, Hatanaka KC, Hirano S
and Matsuno Y: Prognostic significance of epithelial-mesenchymal
transition-related markers in extrahepatic cholangiocarcinoma:
Comprehensive immunohistochemical study using a tissue microarray.
Br J Cancer. 111:1363–1372. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
McKiernan E, McDermott EW, Evoy D, Crown J
and Duffy MJ: The role of S100 genes in breast cancer progression.
Tumour Biol. 32:441–450. 2011. View Article : Google Scholar
|
|
22
|
Rosty C, Ueki T, Argani P, Jansen M, Yeo
CJ, Cameron JL, Hruban RH and Goggins M: Overexpression of S100A4
in pancreatic ductal adenocarcinomas is associated with poor
differentiation and DNA hypomethylation. Am J Pathol. 160:45–50.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Buetti-Dinh A, Pivkin IV and Friedman R:
S100A4 and its role in metastasis - computational integration of
data on biological networks. Mol Biosyst. 11:2238–2246. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Miranda KJ, Loeser RF and Yammani RR:
Sumoylation and nuclear translocation of S100A4 regulate
IL-1beta-mediated production of matrix metalloproteinase-13. J Biol
Chem. 285:31517–31524. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
O'Connell JT, Sugimoto H, Cooke VG,
MacDonald BA, Mehta AI, LeBleu VS, Dewar R, Rocha RM, Brentani RR,
Resnick MB, et al: VEGF-A and Tenascin-C produced by
S100A4+ stromal cells are important for metastatic
colonization. Proc Natl Acad Sci USA. 108:16002–16007. 2011.
View Article : Google Scholar
|
|
26
|
Kim HM, Jung WH and Koo JS: Expression of
cancer-associated fibroblast related proteins in metastatic breast
cancer: An immunohistochemical analysis. J Transl Med. 13:2222015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kang YG, Jung CK, Lee A, Kang WK, Oh ST
and Kang CS: Prognostic significance of S100A4 mRNA and protein
expression in colorectal cancer. J Surg Oncol. 105:119–124. 2012.
View Article : Google Scholar
|
|
28
|
Jung EA, Cho HD, Lee JH and Oh MH:
Clinicopathological significance of S100A4 expression in non-small
cell lung carcinomas. Korean J Pathol. 44:477–482. 2010. View Article : Google Scholar
|
|
29
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang WN, Ai ZH, Wang J, Xu YL and Teng YC:
Correlation between the overexpression of epidermal growth factor
receptor and mesenchymal makers in endometrial carcinoma. J Gynecol
Oncol. 25:36–42. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sack U, Walther W, Scudiero D, Selby M,
Aumann J, Lemos C, Fichtner I, Schlag PM, Shoemaker RH and Stein U:
S100A4-induced cell motility and metastasis is restricted by the
Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells.
Mol Biol Cell. 22:3344–3354. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xie R, Schlumbrecht MP, Shipley GL, Xie S,
Bassett RL Jr and Broaddus RR: S100A4 mediates endometrial cancer
invasion and is a target of TGF-beta1 signaling. Lab Invest.
89:937–947. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Knights AJ, Funnell AP, Crossley M and
Pearson RC: Holding tight: Cell junctions and cancer spread. Trends
Cancer Res. 8:61–69. 2012.PubMed/NCBI
|
|
34
|
Goh Then Sin C, Hersch N, Rudland PS,
Barraclough R, Hoffmann B and Gross SR: S100A4 downregulates
filopodia formation through increased dynamic instability. Cell
Adhes Migr. 5:439–447. 2011. View Article : Google Scholar
|
